Analyst Research

Report Title Price
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Reuters Investment Profile
$20.00
Provider: Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Roche Holding AG acquires IQuum Inc


Monday, 7 Apr 2014 01:01am EDT 

Roche Holding AG:Announces acquisition of IQuum, Inc. (IQuum) based in Marlborough, Massachusetts, USA.IQuum is privately held company focused on developing point of care offerings for molecular diagnostics market.Under terms of agreement, Roche to pay IQuum shareholders $275 million upfront and up to $175 million in contingent product related milestones.Acquisition to provide Roche with access to IQuum’s Laboratory-in-a-tube (Liat) System, which enables healthcare workers to perform rapid molecular diagnostic testing in a point of care setting, closer to patients and with minimal training.The Liat Analyzer and Liat Influenza A/B Assay, first test available for use on system, produce reliable and accurate lab-like results and are CE marked and FDA cleared.Once transaction is complete, IQuum to be integrated into Roche Molecular Diagnostics. 

Company Quote

36.825
0.275 +0.75%
30 Jul 2014